KMKalyan Mitra

Kalyan Mitra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kalyan Mitra has a total of 120 co-authors. Here are the top co-authors by number of shared publications:

  • Arindam Bhattacharjee

    Department of Developmental Biology, Agharkar Research Institute, India

    4 shared publications
  • Bhanu Priya Awasthi

    Electron Microscopy Unit, Sophisticated Analytical Instrument Facility and Research, CSIR—Central Drug Research Institute, Sector-10 , Jankipuram Extension, Lucknow, Uttar Pradesh 226031 , India

    4 shared publications
  • Jayanta Sarkar

    Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India

    4 shared publications
  • Rakesh Kumar Sharma

    Electron Microscopy Unit, Sophisticated Analytical Instrument Facility and Research, CSIR - Central Drug Research Institute, Sector-10, Jankipuram Extension, Lucknow, Uttar Pradesh, 226 031, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India

    4 shared publications
  • Jimut Kanti Ghosh

    Biochemistry and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India

    3 shared publications
  • Juhi Sharma

    CSIR-Central Drug Research Institute Sector 10, Jankipuram Extension, Sitapur Road

    3 shared publications

Latest Publications

  • Neurotrophin-Enriched Extracellular Vesicles Delivery System for Efficient Blood−Brain Barrier Translocation and Neuroprotection

    by Rafquat Rana, Shourya Tripathi, Mahmood Akbar, Sakshi Yadav, Prabha Burman, Keerti Mishra, Pavan K. Yadav, Amrendra K. Tiwari, Animesh K. Gupta, Kalyan Mitra, et al.

    This study addresses the formidable challenge presented by the blood−brain barrier (BBB) in the treatment of neurological diseases by introducing a biomimetic delivery system utilizing extracellular vesicles, which efficiently crosses the BBB without requiring additional targeting moieties. Inspired by the neurotrophic function of the astrocytes, specifically the release of growth factors like Glial-Derived Neurotrophic Factor (GDNF), we harnessed extracellular vesicles from primary astrocytes (ADE), naturally enriched with GDNF (26.18 ± 4.15 pcg/mL), and subsequently coated them onto mesoporous silica nanoparticles loaded with donepezil (DNP), a model drug to formulate ADE_MSN-DNP. The system proposed BBB permeation and cellular uptake, significantly reduced oxidative stress in a Caenorhabditis elegans model, and increased plasma half-life and brain distribution in C57BL/6 male mice (6−8 months old), as estimated through LC−MS/MS and optical live imaging using Coumarin-6 as a fluorescent probe. The enhanced targeting and efficacy are proposed to be primarily attributed to intact GDNF and the intrinsic homing ability of the extracellular vesicles that facilitate efficient delivery of DNP. These findings provide valuable insights into a neurovascular unit-derived extracellular vesicle system that not only targets the brain and crosses the BBB but also offers a forward-looking strategy for neuroprotection in the mitigation of other neurodegenerative diseases.

  • β-Sheet Antimicrobial and Antimycobacterial Peptides with a High Therapeutic Index by Employing the Repeats of a 5-Mer Segment of α-Helical Cytolytic Melittin

    by Rahul Dev Verma, Sariyah Akhtar, Jyotshana Saroj, Juhi Sharma, Mohd Mustkim Ansari, Rahul Verma, Animesh Chaurasia, Mohammad Imran Siddiqi, Bhupendra Narain Singh, Kalyan Mitra, et al.

    Despite strong antimicrobial activity, high haemolytic/cytotoxic properties, associated with its non-cell-selective membrane-lytic property and its large size prohibits considering bee-venom, α-helical, 26-residue, melittin as a lead molecule for antimicrobial-drug development. Herein, we have explored the design of shorter non-haemolytic/non-cytotoxic antimicrobial peptides with low hydrophobic/amphipathic property and β-sheet secondary structure by using a 5-mer carboxy-terminus melittin segment, “WIKRK”, which contains hydrophobic and polar-cationic residues at its two ends. Three peptides, 10-mer, MLT-1, 15-mer, MLT-2, and 20-mer, MLT-3 were designed by taking two, three, and four repeats of “WIKRK”, respectively. MLT-2 and MLT-3 showed β-sheet secondary structure in bacterial membrane-mimetic lipid-vesicles, exhibited negligible haemolytic/cytotoxic properties in comparison to melittin, demonstrated significant antibacterial activities with high therapeutic indexes, and showed anti-mycobacterial activities against a fast/slow-growing strain. Further, MLT-2 and MLT-3 showed appreciable in vivo efficacy against Escherichia coli American Type Culture Collection 25922-infection in mice in the intravenous route and inhibited transcription/translation in in vitro assays suggesting their intracellular mode of action.

  • Open Access

    Cryptic Genes as Building Blocks of Antimicrobial Resistance: Evidence from a Novel Marine Imipenem-Hydrolyzing Metallo-β-Lactamase

    by Pooja Gupta, Pushplata Yadav, Jai Kishan, Saurav Gupta, Surender Shaw, Kamini Goswami, Vikash Chandra Tripathi, Kalyan Mitra, J Venkatesh Pratap, Jesu Arockiaraj, et al.

    The emergence of antimicrobial resistant pathogens has led to increase in mortality rate, longer hospital stays, and need for complex and expensive treatment regimens. However, it is not very clear from where does the bacteria get the building blocks to develop resistance to these synthetic antimicrobial agents which have been integral part of modern medicine. One hypothesis is that non-coding cryptic genes without any vital function or positive contribution to fitness act as versatile endogenous genetic repertoires that help in bacterial adaptation and evolution of new phenotypes when conditions change. This study reports the presence of putative cryptic metallo beta lactamase gene in the marine bacterium Cytobacillus oceanisediminis isolated from the Gulf of Mannar, India. Using in silico, in vitro and in vivo assay, we demonstrate that putative cryptic metallo beta lactamase encodes an enzyme that can cleave only imipenem, has two characteristic domains: HXHXDH and TPGH, but does not share homology with the other reported Metallo-beta-Lactamase genes. The findings underscore the importance for comprehensive screening of putative cryptic antimicrobial resistance genes to fully address and mitigate the challenges posed by antimicrobial resistance.

  • Evaluation of the antileishmanial effects and the mode of action of the natural topoisomerase inhibitor shikonin in Leishmania donovani

    by Swetapadma Majhi, Juhi Sharma, Ravishankar Jaiswal, A L Vishwakarma, Mohammad Imran Siddiqi, Kalyan Mitra

    Aims: Our aim was to evaluate the antileishmanial potential of Shikonin (SKN), a natural topoisomerase inhibitor derived from Lithospermum erythrorhizon, against Leishmania donovani and to elucidate its mechanism of action through physiological, ultrastructural, and in silico studies. Methods and Results: SKN inhibits the in vitro proliferation of both parasite forms, with IC50 values of 3 μM for promastigotes and 0.75 μM for intracellular amastigotes. Using a combination of biophysical and biochemical methods, we found that SKN exerts its cytotoxic effect by generating oxidative stress, mitochondrial dysfunction, and nuclear damage, leading to apoptotic cell death in the parasites. Ultrastructural analysis revealed morphological alterations and apoptotic features in treated parasites, which included mitochondrial swelling and organelle damage, nuclear pyknosis, and pronounced nuclear membrane swelling in the parasites. Since the unique bi-subunit topoisomerase of these parasites has structural differences from the human counterpart and is considered a potential drug target, we performed in-silico molecular docking studies to determine the binding affinity of SKN with topoisomerase 1B (TOP1B). SKN exhibits a stronger binding affinity with L. donovani 1B than the standard topoisomerase inhibitor, camptothecin, forming favorable interactions at the catalytic site. It also shows a lesser binding affinity with human TOP1B than camptothecin. Conclusions: Targeting the Leishmania parasite Topoisomerase with the natural naphthoquinone SKN inhibits parasite proliferation. SKN generates oxidative stress, leading to mitochondrial dysfunction, elevation of cytosolic calcium, and nuclear damage resulting in apoptotic cell death.


  • Open Access

    KAT5-mediated acetylation of PC4 facilitates DNA repair by promoting chromatin reorganization

    by Aayushi Agrawal, Sweta Sikder, Siddharth Singh, Rakesh Kumar Sharma, Nikhil Pallaprolu, Kalyan Mitra, Sourav Mondal, Rupa Mukhopadhyay, Jayanta Sarkar, Ramalingam Peraman, et al.

    Human positive coactivator 4 (PC4) is a highly abundant non-histone chromatin protein involved in diverse cellular processes, including transcription regulation, genome organization, autophagy, B-cell differentiation, neurogenesis, DNA repair, etc. Most PC4 is phosphorylated in cells, which interacts with core histones and the linker histone H1 to confer the compact heterochromatin state of the genome. Knocking down PC4 at both cellular and organismal levels leads to significant chromatin decondensation, altered epigenetic landscape, enhanced autophagy, and increased DNA damage susceptibility. Here, we report that besides p300, PC4 also gets acetylated by DNA repair, facilitating lysine acetyltransferase KAT5 (Tip60) at a specific lysine residue (PC4K80) when the cells are subjected to DNA damage. The vulnerability of DNA in PC4 devoid cells was substantially reduced by reintroducing wild-type PC4 to the cells but not the mutant PC4 (PC4K80R), defective in KAT5-mediated acetylation. High-resolution microscopy techniques, including transmission electron microscopy and atomic force microscopy, are employed to visualize chromatin structural changes in response to DNA damage and repair in a Tip60-mediated PC4 acetylation-dependent manner. Presumably, KAT5-mediated acetylation of PC4 at K80 residue facilitates access to the damaged DNA by altering chromatin structures at damage sites, thus promoting DNA repair. This process could be highly significant both in cancer and in aging.


  • Ormeloxifene induces mitochondrial fission-mediated pro-death autophagy in colon cancer cells

    by Rakesh Kumar Sharma, Rohit Sahai, Nishakumari Chentunarayan Singh, Mayank Maheshwari, Nisha Yadav, Jayanta Sarkar, Kalyan Mitra


  • Open Access

    Augmentation of Antimicrobial Activity of Spiniferin by Introducing an Arginine Residue Toward Its Amino Terminus: A Possible Role of Cation−π Interaction

    by Jyotshana Saroj, Rahul Dev Verma, Sariyah Akhtar, Neeraj Kumar Verma, Arvind Gupta, Arsh Tripathi, Juhi Sharma, Kalyan Mitra, Mohammad Imran Siddiqi, Jimut Kanti Ghosh

    Spiniferin is a 13-mer scorpion-origin antimicrobial peptide having poor antimicrobial activity. To augment Spiniferin’s antimicrobial activity, we enhanced its net positive charge by replacing a glutamic acid residue with an arginine residue toward its amino terminus. We envisaged that a cation−π interaction could be introduced between this arginine residue and the tryptophan residue located near the middle of Spiniferin. This cation−π interaction could promote stronger interaction of the peptide with a negatively charged bacterial membranes, resulting in its increased antimicrobial activity. Though glutamic acid-to-arginine substitution [Spiniferin­(E4R)] enhanced both the antimicrobial and toxic properties of Spiniferin, the same replacement with a d-arginine residue [Spiniferin­(E4dR)] significantly enhanced its antimicrobial activity against selected Gram-negative/positive bacteria and a MRSA strain while maintaining low hemolytic/cytotoxic properties. Interestingly, Spiniferin­(E4dR) analogs, with its aromatic-tryptophan residue substituted with an aromatic phenylalanine or an aliphatic valine residue, and its d-arginine residue replaced with a d-lysine residue, showed much lesser antibacterial activity than Spiniferin­(E4dR) or Spiniferin­(E4R). The results indicated a crucial role of the tryptophan and l-/d-arginine combination in augmenting the antimicrobial activity of Spiniferin analogs, Spiniferin­(E4R) and Spiniferin­(E4dR). Spiniferin­(E4dR) showed bactericidal properties against selected Gram-positive/negative bacteria. It permeabilized bacterial membranes and induced damages in bacterial membrane organization, suggesting that the bacterial plasma membrane is its target for exhibiting antimicrobial activity. Further, Spiniferin­(E4dR) in the intravenous route demonstrated the survival of E. coli ATCC 25922-infected mice and the clearance of bacteria from the visceral organs of these mice. Computational studies showed the requisite distance between the arginine’s cationic side chain and the π-electron site of the tryptophan residue for a possible intramolecular cation−π interaction in Spiniferin­(E4dR)/Spiniferin­(E4R).


  • Buparvaquone Induces Ultrastructural and Physiological Alterations Leading to Mitochondrial Dysfunction and Caspase-Independent Apoptotic Cell Death in Leishmania donovani

    by Swetapadma Majhi, Bhanu Priya Awasthi, Rakesh Kumar Sharma, Kalyan Mitra

    Leishmaniasis is a neglected tropical disease (endemic in 99 countries) caused by parasitic protozoa of the genus Leishmania. As treatment options are limited, there is an unmet need for new drugs. The hydroxynaphthoquinone class of compounds demonstrates broad-spectrum activity against protozoan parasites. Buparvaquone (BPQ), a member of this class, is the only drug licensed for the treatment of theileriosis. BPQ has shown promising antileishmanial activity but its mode of action is largely unknown. The aim of this study was to evaluate the ultrastructural and physiological effects of BPQ for elucidating the mechanisms underlying the in vitro antiproliferative activity in Leishmania donovani. Transmission and scanning electron microscopy analyses of BPQ-treated parasites revealed ultrastructural effects characteristic of apoptosis-like cell death, which include alterations in the nucleus, mitochondrion, kinetoplast, flagella, and the flagellar pocket. Using flow cytometry, laser scanning confocal microscopy, and fluorometry, we found that BPQ induced caspase-independent apoptosis-like cell death by losing plasma membrane phospholipid asymmetry and cell cycle arrest at sub-G0/G1 phase. Depolarization of the mitochondrial membrane leads to the generation of oxidative stress and impaired ATP synthesis followed by disruption of intracellular calcium homeostasis. Collectively, these findings provide valuable mechanistic insights and demonstrate BPQ's potential for development as an antileishmanial agent.